Daiken Biomedical CoTPE:7780 23 EBIT per Share is NT$0.62 as of Dec. 2025. GuruFocus rates TPE:7780 with a GF Score™ of 23/100. The stock has 6 warning signs investors should review. Among 1,581 Consumer Packaged Goods companies, Daiken Biomedical Co ranks worse than 97.6% on this metric.
Daiken Biomedical Co's EBIT per Share for the
three
months ended in Dec. 2025 was NT$0.19.
Its EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2025 was NT$0.62.
During the past 12 months, the average EBIT per Share Growth Rate of Daiken Biomedical Co was 26.50% per year.
During the past 3 years, the average EBIT per Share Growth Rate was -60.90% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for Daiken Biomedical Co's EBIT per Share or its related term are showing as below:
TPE:7780'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -60.9 Med: -60.9 Max: -60.9
Current: -60.9
During the past 4 years, the highest 3-Year average EBIT per Share Growth Rate of Daiken Biomedical Co was -60.90% per year. The lowest was -60.90% per year. And the median was -60.90% per year.
TPE:7780's 3-Year EBIT Growth Rate is ranked worse than 97.6% of 1581
companies
in the Consumer Packaged Goods industry
Industry Median: 6.9
vs TPE:7780: -60.90
Daiken Biomedical Co (TPE:7780) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Daiken Biomedical Co EBIT per Share Related Terms
Daiken Biomedical Co EBIT per Share Historical Data
* Premium members only.
The historical data trend for Daiken Biomedical Co's EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$0.62
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Daiken Biomedical Co (TPE:7780) has a EBIT per Share of NT$0.62 as of Dec. 2025. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Daiken Biomedical Co and its competitors. According to the industry distribution chart, Daiken Biomedical Co ranks #1543 out of 1581 companies in the Consumer Packaged Goods industry, placing it in the top 97.6%.
Is Daiken Biomedical Co's EBIT per Share too high?
Daiken Biomedical Co's current EBIT per Share is NT$0.62. Based on the distribution chart, Daiken Biomedical Co ranks #1543 out of 1581 companies in the Consumer Packaged Goods industry, which is in the bottom quartile relative to peers. Overall, Daiken Biomedical Co has a GF Score™ of 23/100, reflecting its overall financial health beyond just this single metric.
How does Daiken Biomedical Co's EBIT per Share compare to KHC and GIS?
According to the Consumer Packaged Goods industry distribution chart, Daiken Biomedical Co ranks #1543 out of 1581 companies for EBIT per Share. This places Daiken Biomedical Co in the lower half of its industry. The industry median EBIT per Share is 6.90. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Consumer Packaged Goods company?
The median EBIT per Share among Consumer Packaged Goods companies is 6.90, based on 1,581 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Daiken Biomedical Co and its competitors. For the Consumer Packaged Goods industry, the median EBIT per Share is 6.90 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Daiken Biomedical Co's current EBIT per Share is NT$0.62. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Daiken Biomedical Co stock overvalued right now?
Daiken Biomedical Co (TPE:7780) has a current EBIT per Share of NT$0.62. The current EBIT per Share is NT$0.62. Daiken Biomedical Co's overall GF Score™ is 23/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Daiken Biomedical Co (TPE:7780), the current EBIT per Share is NT$0.62 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Daiken Biomedical Co Ltd is engaged in Research, development, and sales of health food. Its products include fish oil capsules, collagen powder, collagen drinks, natto capsules, and mint leaf capsules. The companies reportable operating segment consists solely of the e-commerce division.
23GF Score
Get the complete analysis for TPE:7780
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TPE:7780 has been successfully added to your 
